Back to overview

A Multicenter, Open-label STudy of netarsudil for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension in a real-world setting

Posted:
Share

You are on a website for Health Care Professionals in the United States

By clicking below “OK” you acknowledge that this site is intended for Health Care professionals only
OK Other country